4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-21-069351
Director bought 150,000 shares at an average $3.66 ($549,692)
From the SEC's structured data for this filing
Trades in this filing
Shanafelt Armen · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-09 | Purchase : show line 1 in the form | +121,799 | $3.67 | $446,759 | 121,799 | D |
| 2021-12-10 | Purchase : show line 2 in the form | +13,516 | $3.65 | $49,333 | 135,315 | D |
| 2021-12-13 | Purchase : show line 3 in the form | +14,685 | $3.65 | $53,600 | 150,000 | D |
| Open-market purchases · 150,000 sh · avg $3.66 · $549,692 | ||||||
Loading xslF345X03/doc4.xml…